Old Web
English
Sign In
Acemap
>
Paper
>
Daratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study)
Daratumumab As a Treatment for Adult Immune Thrombocytopenia: A Phase II Study with Safety Run-in (the DART Study)
2021
Galina Tsykunova
Pål-Andre Holme
Hoa Thi Tuyet Tran
Tor Henrik Anderson Tvedt
Ludvig A. Munthe
Marc Michel
Henrik Frederiksen
James B. Bussel
David J. Kuter
Waleed Ghanima
Keywords:
Daratumumab
Immunology
immune thrombocytopenia
Phases of clinical research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]